AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 294: E1109-E1118, 2008. First published April 15, 2008; doi:10.1152/ajpendo.00016.2008
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/6/E1109    most recent
00016.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Ueno, M.
Right arrow Articles by Miyamori, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueno, M.
Right arrow Articles by Miyamori, I.

Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice

Masami Ueno,1 Jinya Suzuki,1 Yasuo Zenimaru,1 Sadao Takahashi,1 Tsutomu Koizumi,2 Sakon Noriki,3 Osamu Yamaguchi,4 Kinya Otsu,4 Wen-Jun Shen,5,6 Fredric B. Kraemer,5,6 and Isamu Miyamori1

1Third Department of Internal Medicine, 2Laboratory Animal Resources, and 3Department of Pathology, University of Fukui, Fukui; 4Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; 5Veterans Affairs Palo Alto Health Care System, Palo Alto; and 6Division of Endocrinology, Stanford University, Stanford, California

Submitted 9 January 2008 ; accepted in final form 10 April 2008

Intracellular lipid accumulation (steatosis) and resultant lipotoxicity are key features of diabetic cardiomyopathy. Since cardiac hormone-sensitive lipase (HSL) is activated in diabetic mice, we sought to explore a pathophysiological function of cardiac HSL in the development of diabetic cardiomyopathy. Transgenic (Tg) mice with heart-specific HSL overexpression were generated, and cardiac histology, function, lipid profile, and gene expressions were analyzed after induction of diabetes by streptozotocin. Electron microscopy showed numerous lipid droplets in wild-type (Wt) hearts after 3 wk of diabetes, whereas Tg mice showed no lipid droplet accumulation. Cardiac content of acylglycerides was increased ~50% with diabetes in Wt mice, whereas this was blunted in Tg hearts. Cardiac lipid peroxide content was twofold lower in Tg hearts than in Wt hearts. The mRNA expressions for peroxisome proliferator-activated receptor-{alpha}, genes for triacylglycerol synthesis, and lipoprotein lipase were increased with diabetes in Wt hearts, whereas this induction was absent in Tg hearts. Expression of genes associated with lipoapoptosis was decreased, whereas antioxidant protein metallothioneins were increased in diabetic Tg hearts. Diabetic Wt hearts showed interstitial fibrosis and increased collagen content. However, Tg hearts displayed no overt fibrosis, concomitant with decreased expression of collagens, transforming growth factor-β, and matrix metalloproteinase 2. Notably, mortality during the experimental period was approximately twofold lower in diabetic Tg mice compared with Wt mice. In conclusion, since HSL overexpression inhibits cardiac steatosis and fibrosis by apparently hydrolyzing toxic lipid metabolites, cardiac HSL could be a therapeutic target for regulating diabetic cardiomyopathy.

lipotoxicity; lipolysis; animal model; transgenic mice


Address for reprint requests and other correspondence: J. Suzuki, Third Dept. of Internal Medicine, Univ. of Fukui, Faculty of Medical Science, Fukui 910-1193, Japan (e-mail: jinya{at}u-fukui.ac.jp)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.